Evidence map›Paper›PMID 41784898›Full record

ArticleThe Saudi dental journal2026

Serum total sialic acid and carcinoembryonic antigen as biomarkers in diagnosis and stratification of oral squamous cell carcinoma, oral submucous fibrosis, and periodontitis: a prospective cross-sectional analytical study.

Saleena Mishra, Swagatika Panda, Subrat Tripathy, Satya Ranjan Mishra, Neeta Mohanty, Swati Mishra

Abstract read
In one paragraph

Article in The Saudi dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Saleena MishraDepartment of Oral Pathology and Microbiology, Institute of Dental Sciences, Siksha' O' Anusandhan, Deemed to Be University, Bhubaneswar, Odisha, 751003, India.
Swagatika PandaDepartment of Oral Pathology and Microbiology, Institute of Dental Sciences, Siksha' O' Anusandhan, Deemed to Be University, Bhubaneswar, Odisha, 751003, India. swagatikapanda@soa.ac.in.ORCID http://orcid.org/0000-0002-7449-3974
Subrat TripathyDepartment of Biochemistry, Institute of Medical Sciences, Siksha' O' Anusandhan, Deemed to Be University, Bhubaneswar, Odisha, 751003, India.
Satya Ranjan MishraDepartment of Oral Medicine and Radiology, Institute of Dental Sciences, Siksha' O' Anusandhan, Deemed to Be University, Bhubaneswar, Odisha, 751003, India.
Neeta MohantyDepartment of Oral Pathology and Microbiology, Institute of Dental Sciences, Siksha' O' Anusandhan, Deemed to Be University, Bhubaneswar, Odisha, 751003, India.
Swati MishraGeneral Dental Practitioner, Odisha, 757001, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOral squamous cell carcinoma (OSCC) often arises from oral submucous fibrosis (OSMF), one of the common oral potentially malignant disorders (OPMDs). Identifying reliable biomarkers for early diagnosis of both OSMF and OSCC is crucial for reducing the mortality and morbidity. This study investigates the diagnostic potential of serum carcinoembryonic antigen (CEA) and total sialic acid (TSA) in OSCC and OSMF and identifies the cut-off value to facilitate the objectivity in diagnosing. Additionally, this study highlighted the differences in serum TSA between chronic generalised periodontitis (CGP) with and without OSCC. This study also evaluated the association of serum CEA and TSA with clinicopathological features of OSMF, and OSCC.

methodsThis prospective cross-sectional analytical study included 142 participants divided into five groups. Group I, II, and III comprised of healthy individuals (n = 39), OSMF patients (n = 39), and OSCC patients (n = 39) respectively. Among group III, 25 patients having CGP were categorized as group IV and additional 25 patients having CGP but without OSCC were categorized as group V. Serum TSA and CEA levels were measured using UV spectrophotometry and electrochemiluminescence assay, respectively. The normalcy of the data was examined followed by comparison of mean serum CEA and TSA between and among the groups by Mann-Whitney U test and Kruskal-wallis test. Linear regression analysis evaluated the association of serum CEA and TSA with clinicopathological features. Receiver operating characteristic (ROC) curves plotted to identify the cutoff values of serum CEA and TSA in each group.

resultsSerum TSA levels progressively increased from Group I (0.416 ± 0.105 nmol/mg) to II (0.787 ± 0.097 nmol/mg) and III (0.869 ± 0.088 nmol/mg), with significant differences among the groups (p < 0.001). TSA levels were significantly higher in Group IV (0.917 ± 0.070 nmol/mg) compared to Group V (0.739 ± 0.123 nmol/mg; p < 0.001). Serum CEA levels also showed a progressive elevation from group I (1.77 ± 0.42 ng/mL), to II (2.90 ± 0.58 ng/mL), and III (3.62 ± 0.56 ng/mL), with significant intergroup differences (p < 0.001). Both biomarkers were significantly associated with advanced clinical stage and histopathological grade in Group II and III. TSA and CEA demonstrated high sensitivity and specificity for OSCC diagnosis, with optimal cutoff values of 0.64 nmol/mg for TSA and 2.4 ng/mL for CEA.

conclusionsSerum TSA and CEA are promising biomarkers for the early diagnosis and differentiation of OSCC and OSMF. TSA also helps distinguish periodontitis associated with OSCC from periodontitis without OSCC. Their significant association with clinical stage and histopathological grade underscores their potential role in disease progression assessment. Future studies should explore these findings in larger populations and combining the present data point of care diagnostics can be conceptualized.

Indexed as

Carcinoembryonic antigenOral squamous cell carcinomaOral submucous fibrosisPeriodontitisTotal sialic acid

Identifiers

PMID41784898
PMCPMC12963032

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.